Identification of key genes and pathways involved in microsatellite instability in colorectal cancer.
Journal
Molecular medicine reports
ISSN: 1791-3004
Titre abrégé: Mol Med Rep
Pays: Greece
ID NLM: 101475259
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
17
04
2018
accepted:
14
11
2018
pubmed:
22
1
2019
medline:
28
5
2019
entrez:
22
1
2019
Statut:
ppublish
Résumé
Microsatellite instability (MSI) has emerged as one of the key biological features of colorectal cancer (CRC). However, controversies remain regarding the association between the MSI status and clinicopathological characteristics of CRC. Therefore, it is crucial to identify potential key genes and pathways associated with MSI in CRC. In the present study, the GSE25071 gene expression profile was retrieved, with thirty‑eight cases of microsatellite stable (MSS), five of MSI‑High (MSI‑H) and three of MSI‑Low (MSI‑L) CRC patients. The differentially expressed genes (DEGs) were analyzed by Gene Ontology (GO), Kyoto Encyclopedia of Genes and Genomes pathway enrichment, gene set enrichment analysis (GSEA) and gene co‑expression network analysis. Weighted gene correlation network analysis (WGCNA) was used for the gene modules and correlation of clinical traits. A total of forty‑nine DEGs were identified between MSI‑H and MSS, including six upregulated and forty‑three downregulated DEGs. Only the DEGs of MSI‑H and MSS were subjected to subsequent analysis (limited number of DEGs of MSI‑L and MSS, MSI‑H and MSI‑L). RNA metabolic process, endoplasmic reticulum and chemokine receptor binding were the top ranked terms in GO enrichment. The hub genes of co‑expression network of DEGs included zinc finger protein (ZNF) 813, ZNF426, ZNF611, ZNF320 and ZNF573. The GSEA of MSI‑H and MSS indicated that the mammalian target of rapamycin complex 1 signaling was significantly enriched with a nominal P‑value of 0.038 and normalized enrichment score of 0.446. The WGCNA results showed that the pink module was the top in correlation with MSI status (R2=0.5, P=0.0004). The genes in the pink module were significantly enriched in proteins targeting to endoplasmic reticulum, cytosolic part, structural constituent of ribosome and ribosome pathway. The hub genes identified in the pink module were ribosomal protein L12 (RPL12), RPS3A, RPS9, RPL27A, RPL7, RPL28, RPL14, RPS17, mitochondrial ribosomal protein L16, and G elongation factor, mitochondrial 2. The present study identified key genes and pathways associated with MSI, providing insightful mechanisms.
Identifiants
pubmed: 30664178
doi: 10.3892/mmr.2019.9849
pmc: PMC6390070
doi:
Substances chimiques
Neoplasm Proteins
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2065-2076Références
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Curr Opin Struct Biol. 2001 Feb;11(1):39-46
pubmed: 11179890
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
BMC Bioinformatics. 2003 Jan 13;4:2
pubmed: 12525261
J Clin Oncol. 2003 Mar 15;21(6):1174-9
pubmed: 12637487
Nat Rev Cancer. 2003 May;3(5):330-8
pubmed: 12724731
N Engl J Med. 2003 Jul 17;349(3):247-57
pubmed: 12867608
Lancet. 1992 Sep 12;340(8820):626-30
pubmed: 1355210
J Mol Biol. 1962 Mar;4:193-210
pubmed: 14460744
Genome Res. 2003 Nov;13(11):2498-504
pubmed: 14597658
Oncogene. 2004 Apr 19;23(18):3151-71
pubmed: 15094765
J Clin Oncol. 2005 Jan 20;23(3):609-18
pubmed: 15659508
JAMA. 2005 Apr 27;293(16):1986-94
pubmed: 15855432
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Stat Appl Genet Mol Biol. 2005;4:Article17
pubmed: 16646834
Bioinformatics. 2007 Jul 15;23(14):1846-7
pubmed: 17496320
Clin Cancer Res. 2007 Jun 1;13(11):3109-14
pubmed: 17545512
Gut. 2008 Jul;57(7):941-50
pubmed: 18364437
Clin Cancer Res. 2008 Dec 15;14(24):8061-9
pubmed: 19088021
BMC Bioinformatics. 2008 Dec 29;9:559
pubmed: 19114008
Nat Protoc. 2009;4(1):44-57
pubmed: 19131956
BMC Med Genomics. 2009 Apr 24;2:18
pubmed: 19393097
N Engl J Med. 2009 Dec 17;361(25):2449-60
pubmed: 20018966
J Clin Oncol. 2010 Jul 10;28(20):3380-7
pubmed: 20516444
Nucleic Acids Res. 2010 Jul;38(Web Server issue):W214-20
pubmed: 20576703
Lancet Oncol. 2011 Jun;12(6):594-603
pubmed: 21163703
PLoS One. 2010 Dec 22;5(12):e15661
pubmed: 21203531
Int J Colorectal Dis. 2011 Jul;26(7):847-58
pubmed: 21465190
Genes Immun. 2011 Dec;12(8):653-62
pubmed: 21716316
Cell. 2012 Apr 13;149(2):410-24
pubmed: 22424946
Nature. 2012 Jul 18;487(7407):330-7
pubmed: 22810696
Nat Med. 2013 May;19(5):614-8
pubmed: 23584090
J Pathol. 2013 Sep;231(1):63-76
pubmed: 23836465
Gastroenterology. 2014 Sep;147(3):595-598.e5
pubmed: 24941021
Nucleic Acids Res. 2015 Jan;43(Database issue):D447-52
pubmed: 25352553
Hum Pathol. 2015 May;46(5):753-60
pubmed: 25776026
Proteomics. 2015 Aug;15(15):2597-601
pubmed: 25921073
Oncotarget. 2015 Dec 8;6(39):42334-44
pubmed: 26517354
N Engl J Med. 2015 Nov 12;373(20):1979
pubmed: 26559582
CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32
pubmed: 26808342
Cell. 2016 Mar 24;165(1):35-44
pubmed: 26997480
CA Cancer J Clin. 2017 May 6;67(3):177-193
pubmed: 28248415
J Natl Compr Canc Netw. 2017 Mar;15(3):370-398
pubmed: 28275037
N Engl J Med. 1998 May 21;338(21):1481-7
pubmed: 9593786